Printer Friendly Printed from http://www.researchandmarkets.com/reports/227828 A Guide to Pharmacovigilance in the EU. Description: Although the legislative framework for pharmacovigilance has not changed significantly in the last two years, there are still many companies, especially smaller organizations, which appear to struggle to meet these requirements. All companies have a statutory obligation to seek information about potential problems in the use of their medicinal products - it is not an option. Failure to do so can result in criminal prosecution against individuals in the company. It is vital that all companies with EU marketing authorizations have mechanisms in place for obtaining, recording, storing, and submitting suspected adverse drug reactions to the regulatory authorities in the countries in which the authorizations are valid. This requirement applies to both national authorizations obtained through the mutual recognition procedure and EU-wide authorizations obtained through the centralized procedure. Scope of the Guide - This Guide provides a thorough evaluation of pharmacovigilance issues that is essential for all those in regulatory affairs, clinical studies, post-marketing surveillance, and all aspects of the maintenance of marketing authorizations in the EU. In addition, the Guide offers detailed information to assist those requiring a primer to effectively carry out their roles in pharmacovigilance and related activities. Questions Answered: - Who is involved in the collection, management, distribution, and analysis of suspected adverse drug reaction information? - What is the legislative framework for pharmacovigilance in Europe? - What are the reporting requirements for suspected adverse drug reactions for all products approved in the EU irrespective of the method of product registration? - Why is pharmacovigilance so important to the maintenance of safe medicinal products on the market and to public confidence in the industry and its products? - How do the marketing authorization holders and the regulatory authorities deal with concerns about particular medicinal products? Target Audience: This Guide will benefit the following professionals who have or are seeking to obtain marketing authorizations within the EU: Regulatory Affairs, Clinical Research, Directors, Group Leaders, Project Managers, Heads of Research & Development, Business Development, Marketing, Consultants, and more Contents: 1. Introduction 2. Brief Historical Perspectives 3. Legislative Framework 4. Eudra Vigilance 5. ADR Reporting Requirements for Companies 6. Reporting Requirements in Special Situations 7. Spontaneous Reporting 8. Prescription Event Monitoring 9. Statistical Analysis of ADRs 10. Periodic Safety Update Reports 11. Company-Sponsored Post-Authorization Safety Studies 12. Pharmacovigilance Evaluation Post-Authorization 13. Managing and Maximizing a Data Source for Pharmacovigilance: The General Practice Research Database (GPRD) 14. The Future for Pharmacovigilance Ordering: Order Online - visit http://www.researchandmarkets.com/reports/227828 Order by Fax - using the order form below Order By Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Printed 30/08/2008 13:15:50 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com Order information Please verify that the product information is correct and select the format you require. Product Name: A Guide to Pharmacovigilance in the EU. Web Address: http://www.researchandmarkets.com/reports/227828 Office Code: OCHGMKQKRRQ Report formats Please enter the quantity of the report format you require. Format Quantity Price Electronic €423.00 Contact information Please enter all the information below in BLOCK CAPITALS. First Name:   Last Name:   Email Address: Job Title: Organisation: Address: City: Postal/Zip Code: Country: Phone Number: Fax Number: Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World Page 2 of 2 Printed 30/08/2008 13:15:50 Payment information Please indicate the payment method you would like to use by selecting the appropriate box.  Pay by Credit Card: American Express Diners Club Master Card Visa Cardholder Name: Expiry Date: / Card Number: CVV Security Code: Issue Date: /   (Diners Club only)  Pay by Check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.  Pay by Wire Transfer: Please transfer funds to: Account number: 83313083 Sort code: 98-53-30 Swift code: ULSBIE2D IBAN number: IE78ULSB98533083313083 Bank Address: Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World